Inspire Medical Systems (INSP) Cash & Equivalents Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -22.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 23.57% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -7.71% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 156.03% |
| 10 | Inspire Medical Systems | 1.17 Bn | 889.44 Mn | 176.91 Mn | 83.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83.61% |
| Dec 31, 2025 | -30.19% |
| Sep 30, 2025 | -23.50% |
| Jun 30, 2025 | -43.13% |
| Mar 31, 2025 | -69.28% |
| Dec 31, 2024 | -19.07% |
| Sep 30, 2024 | -55.29% |
| Jun 30, 2024 | -59.74% |
| Mar 31, 2024 | -60.32% |
| Dec 31, 2023 | -57.98% |
| Sep 30, 2023 | -21.04% |
| Jun 30, 2023 | 150.34% |
| Mar 31, 2023 | 117.49% |
| Dec 31, 2022 | 105.90% |
| Sep 30, 2022 | 98.77% |
| Jun 30, 2022 | 5.68% |
| Mar 31, 2022 | 11.49% |
| Dec 31, 2021 | 12.57% |
| Sep 30, 2021 | 17.62% |
| Jun 30, 2021 | -16.43% |
| Mar 31, 2021 | 139.56% |
| Dec 31, 2020 | 733.41% |
| Sep 30, 2020 | 271.96% |
| Jun 30, 2020 | 312.03% |
| Mar 31, 2020 | -25.34% |
| Dec 31, 2019 | -76.50% |
| Sep 30, 2019 | 82.59% |
| Jun 30, 2019 | -57.93% |
| Mar 31, 2019 | 814.55% |
| Dec 31, 2018 | 986.41% |
| Sep 30, 2018 | 80.96% |
| Jun 30, 2018 | 441.40% |
| Mar 31, 2018 | -58.02% |